Aarti Drugs Ltd
AARTIDRUGS
Company Profile
Business description
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.
Contact
Road No. 29, Plot Number 109-D
Mahendra Industrial Estate, Ground Floor
Sion (East)
MumbaiMH400022
INDT: +91 2224019025
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
2,766
Stocks News & Analysis
stocks
Distribution growth for ASX income play
Cost containment and growing revenue bode well for profit margins.
stocks
We take a different view to market on ASX bloodbath
Sales growth at CSL was lower than expected but streamlining the business has its perks.
stocks
BHP earnings weaker with lower iron ore prices more than offsetting higher copper volumes
Results were softer than expected.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,177.40 | 3.60 | 0.04% |
| CAC 40 | 7,973.03 | 6.05 | -0.08% |
| DAX 40 | 24,276.97 | 146.10 | -0.60% |
| Dow JONES (US) | 44,938.31 | 16.04 | 0.04% |
| FTSE 100 | 9,288.14 | 98.92 | 1.08% |
| HKSE | 25,165.94 | 43.04 | 0.17% |
| NASDAQ | 21,172.86 | 142.09 | -0.67% |
| Nikkei 225 | 42,888.55 | 657.74 | -1.51% |
| NZX 50 Index | 13,071.30 | 142.62 | 1.10% |
| S&P 500 | 6,395.78 | 15.59 | -0.24% |
| S&P/ASX 200 | 8,918.00 | 21.80 | 0.25% |
| SSE Composite Index | 3,766.21 | 38.92 | 1.04% |